# Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

> **NCT00598273** · PHASE3 · COMPLETED · sponsor: **Affymax** · enrollment: 490 (actual)

## Conditions studied

- Chronic Renal Failure
- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** peginesatide
- **DRUG:** peginesatide
- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT00598273
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-03
- **Final completion:** 2010-02
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2013-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598273, "Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00598273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*